Home > Healthcare > Medical Devices > Rehabilitation and Assistive Devices > Wheelchair Mounted Robotic Arm Market
Based on application, the wheelchair mounted robotic arm market is bifurcated into spinal cord injury, neurological conditions, and others. Neurological conditions accounted for USD 7.9 million in 2022 and is anticipated to grow at a lucrative pace by 2032. Neurological conditions often result in mobility impairments, and wheelchair mounted robotic arms can offer valuable assistance to individuals with such conditions. Neurological conditions like cerebral palsy, multiple sclerosis, and amyotrophic lateral sclerosis (ALS) can lead to varying degrees of mobility impairment. Wheelchair mounted robotic arms provide a means for individuals to regain some degree of independence by assisting with mobility.
The U.S. wheelchair mounted robotic arm market is expected to reach around USD 13.8 million by 2032. This high market share is owing to increasing disabled population, rising healthcare expenditure, technological advancements, growing disposable income, etc. in the region. Moreover, rising incidences of neurological diseases such as stroke, multiple sclerosis, traumatic brain injuries, etc. is anticipated to fuel the product demand. For instance, according to the CDC data, in 2021, around 795,000 people in the U.S. suffer from stroke every year and hence there is a growing awareness towards stroke management among the target population. This prevalent disorder can lead to paralysis or mobility impairments contributing to the enhanced adoption of wheelchair mounted robotic arm.
Moreover, further, availability of advanced healthcare facilities coupled with highly skilled medical professionals enhances the market trends. Additionally, availability of novel health technologies in the region is anticipated to augment the market growth in the U.S.